Noninvasive Positive Pressure Ventilation Using a Helmet in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Feasibility Study

Massimo Antonelli, Mariano Alberto Pennisi, Paolo Pelosi, Cesare Gregoretti, Vincenzo Squadrone, Monica Rocco, Luca Cecchini, Davide Chiumello, Paolo Severgnini, Rodolfo Proietti, Paolo Navalesi, Giorgio Conti

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Noninvasive positive pressure ventilation (NPPV) with a facemask (FM) is effective in patients with acute exacerbation of their chronic obstructive pulmonary disease. Whether it is feasible to treat these patients with NPPV delivered by a helmet is not known. Methods: Over a 4-month period, the authors studied 33 chronic obstructive pulmonary disease patients with acute exacerbation who were admitted to four intensive care units and treated with helmet NPPV. The patients were compared with 33 historical controls treated with FM NPPV, matched for simplified acute physiologic score (SAPS II), age, PaCO 2, pH, and PaO 2: fractional inspired oxygen tension. The primary endpoints were the feasibility of the technique, improvement of gas exchange, and need for intubation. Results: The baseline characteristics of the two groups were similar. Ten patients in the helmet group and 14 in the FM group (P = 0.22) were intubated. In the helmet group, no patients were unable to tolerate NPPV, whereas five patients required intubation in the FM group (P = 0.047). After 1 h of treatment, both groups had a significant reduction of PaCO 2 with improvement of pH; PaCO 2 decreased less in the helmet group (P = 0.01). On discontinuing support, PaCO 2 was higher (P = 0.002) and pH lower (P = 0.02) in the helmet group than in the control group. One patient in the helmet group, and 12 in the FM group, developed complications related to NPPV (P <0.001). Length of intensive care unit stay, intensive care unit, and hospital mortality were similar in both groups. Conclusions: Helmet NPPV is feasible and can be used to treat chronic obstructive pulmonary disease patients with acute exacerbation, but it does not improve carbon dioxide elimination as efficiently as does FM NPPV.

Original languageEnglish
Pages (from-to)16-24
Number of pages9
JournalAnesthesiology
Volume100
Issue number1
DOIs
Publication statusPublished - Jan 2004

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Noninvasive Positive Pressure Ventilation Using a Helmet in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Feasibility Study'. Together they form a unique fingerprint.

Cite this